S&P 500 7,420.10 â–ŧ 91.25 (-1.21%) DOW 51,492.55 â–ŧ 507.12 (-0.98%) NASDAQ 26,021.66 â–ŧ 354.69 (-1.34%) US Markets Closed â€ĸ 07:37 AM ET

CPMV

Mosaic ImmunoEngineering, Inc.

Price Chart
Latest Quote

$0.67

+0.00 (+0.00%)
Current Price
Previous Close $0.67
Open $0.69
Day High $0.69
Day Low $0.69
Volume 100
Fetched: 2026-06-18T11:37:30
Stock Information
Shares Outstanding 7.24M
Total Debt $1.68M
Cash Equivalents $72
Net Income $-682K
Sector Healthcare
Industry Biotechnology
Market Cap $4.88M
EPS (TTM) $-0.09
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$6.57M
Income$-682K
Book/sh$-1.06
Cash/sh$0.00
Employees2
Financial Ratios
Current Ratio0.00
Returns & Margins
ROA-692.47%
Ownership
Insider Ownership88.68%
Insider & Institutional transactions data not available
Valuation Ratios
PEG0.87
P/B-0.64
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.64
SMA50$0.67
SMA200$0.60
RSI45.89
ATR0.1005
Shares Float820K
Volatility-0.79
Performance History
Week+0.00%
Month-3.02%
Quarter+34.80%
6 Months+68.50%
YTD+116.72%
Year+104.86%
3 Years-20.71%
5 Years-66.30%
10 Years-66.30%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-17 $0.67 0
2026-06-16 $0.67 0
2026-06-15 $0.67 0
2026-06-12 $0.67 0
2026-06-11 $0.67 0
2026-06-10 $0.67 0
2026-06-09 $0.67 700
2026-06-08 $0.67 0
2026-06-05 $0.67 0
2026-06-04 $0.67 0
2026-06-03 $0.67 200
2026-06-02 $0.33 0
2026-06-01 $0.33 900
2026-05-29 $0.39 500
2026-05-28 $0.74 0
2026-05-27 $0.74 0
2026-05-26 $0.74 4,700
2026-05-22 $0.69 0
2026-05-21 $0.69 0
2026-05-20 $0.69 0
2026-05-19 $0.69 0
2026-05-18 $0.69 0
About Mosaic ImmunoEngineering, Inc.

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.

📰 Latest News
No news articles available at the moment. Check back later for updates on CPMV.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $81,933 $89,175 $151,581 $160,148
Total Expenses $879,655 $1,399,768 $2,627,522 $3,501,166
Other Income Expense $42,000 $479,700 $400,600 $-20,800
Other Non Operating Income Expenses $42,000 $433,000 $343,000 -
Net Non Operating Interest Income Expense $-81,928 $-85,767 $-151,548 $-160,112
Interest Expense Non Operating $81,933 $89,175 $151,581 $160,148
Operating Expense $879,655 $1,399,768 $2,627,522 $3,501,166
General And Administrative Expense $695,788 $964,319 $1,579,065 $2,045,047
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Net Interest Income $-81,928 $-85,767 $-151,548 $-160,112
Interest Income $5 $3,408 $33 $36
Normalized Income $-921,983 $-1,045,128 $-2,426,374 $-3,669,294
Net Income From Continuing And Discontinued Operation $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Total Operating Income As Reported $-879,655 $-1,399,768 $-2,627,522 $-3,501,166
Net Income Common Stockholders $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Net Income $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Net Income Including Noncontrolling Interests $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Net Income Continuous Operations $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Pretax Income $-919,583 $-1,005,835 $-2,378,470 $-3,682,078
Interest Income Non Operating $5 $3,408 $33 $36
Operating Income $-879,655 $-1,399,768 $-2,627,522 $-3,501,166
Earnings From Equity Interest - - - $0
Per Share
Diluted EPS $-0.13 $-0.14 $-0.33 $-0.55
Basic EPS $-0.13 $-0.14 $-0.33 $-0.55
Other
Tax Effect Of Unusual Items $0 $9,807 $12,096 $-5,616
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-837,650 $-963,360 $-2,284,489 $-3,501,130
EBITDA (Bullshit earnings) $-837,650 $-916,660 $-2,226,889 $-3,521,930
EBIT $-837,650 $-916,660 $-2,226,889 $-3,521,930
Diluted Average Shares $7,236,447 $7,236,447 $7,235,609 $6,712,675
Basic Average Shares $7,236,447 $7,236,447 $7,235,609 $6,712,675
Diluted NI Availto Com Stockholders $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Tax Provision $2,400 $2,400 $2,400 $2,400
Research And Development $183,867 $435,449 $1,048,457 $1,456,119
Selling General And Administration $695,788 $964,319 $1,579,065 $2,045,047
Other Gand A $695,788 $964,319 $1,579,065 $2,045,047
Total Unusual Items - $46,700 $57,600 $-20,800
Total Unusual Items Excluding Goodwill - $46,700 $57,600 $-20,800
Gain On Sale Of Security - $46,700 $57,600 $-20,800
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-6,788,174 $-5,871,058 $-4,884,758 $-2,799,011
Total Assets $141,611 $179,533 $261,277 $269,494
Total Non Current Assets $0 $0 $0 $0
Current Assets $141,611 $179,533 $261,277 $269,494
Other Current Assets $26,592 $23,355 $40,632 $43,352
Cash Cash Equivalents And Short Term Investments $115,019 $156,178 $220,645 $226,142
Cash And Cash Equivalents $115,019 $156,178 $220,645 $226,142
Prepaid Assets - - - $43,352
Receivables - - - $0
Taxes Receivable - - - $0
Debt
Net Debt $1,477,496 $1,161,358 $1,007,716 $509,006
Total Debt $1,592,515 $1,317,536 $1,228,361 $735,148
Long Term Debt And Capital Lease Obligation $1,392,515 $1,317,536 $1,228,361 $735,148
Long Term Debt $1,392,515 $1,317,536 $1,228,361 $735,148
Current Debt And Capital Lease Obligation $200,000 - - -
Current Debt $200,000 - - -
Other Current Borrowings $200,000 - - -
Liabilities
Total Liabilities Net Minority Interest $6,929,785 $6,050,591 $5,146,035 $3,068,505
Total Non Current Liabilities Net Minority Interest $1,392,515 $1,317,536 $1,228,361 $735,148
Current Liabilities $5,537,270 $4,733,055 $3,917,674 $2,333,357
Other Current Liabilities $177,244 $177,244 $223,944 $281,544
Payables And Accrued Expenses $1,392,374 $1,370,900 $1,294,598 $660,516
Payables $134,865 $118,478 $133,464 $113,513
Accounts Payable $134,865 $118,478 $133,464 $113,513
Equity
Common Stock Equity $-6,788,175 $-5,871,059 $-4,884,759 $-2,799,012
Preferred Stock Equity $1 $1 $1 $1
Total Equity Gross Minority Interest $-6,788,174 $-5,871,058 $-4,884,758 $-2,799,011
Stockholders Equity $-6,788,174 $-5,871,058 $-4,884,758 $-2,799,011
Retained Earnings $-8,838,320 $-7,916,337 $-6,908,102 $-4,527,232
Other
Ordinary Shares Number $7,242,137 $7,242,137 $7,242,137 $7,241,137
Share Issued $7,242,137 $7,242,137 $7,242,137 $7,241,137
Tangible Book Value $-6,788,175 $-5,871,059 $-4,884,759 $-2,799,012
Invested Capital $-5,195,660 $-4,553,523 $-3,656,398 $-2,063,864
Working Capital $-5,395,659 $-4,553,522 $-3,656,397 $-2,063,863
Total Capitalization $-5,395,659 $-4,553,522 $-3,656,397 $-2,063,863
Additional Paid In Capital $2,050,073 $2,045,206 $2,023,271 $1,728,148
Capital Stock $73 $73 $73 $73
Common Stock $72 $72 $72 $72
Preferred Stock $1 $1 $1 $1
Pensionand Other Post Retirement Benefit Plans Current $3,767,652 $3,184,911 $2,399,132 $1,391,297
Current Accrued Expenses $1,257,509 $1,252,422 $1,161,134 $547,003
Other Short Term Investments - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-241,159 $-497,467 $-690,129 $-679,236
Operating Activities
Operating Cash Flow $-241,159 $-497,467 $-690,129 $-679,236
Cash Flow From Continuing Operating Activities $-241,159 $-497,467 $-690,129 $-679,236
Operating Gains Losses - $-479,700 $-400,600 $20,800
Investing Activities
Investing Cash Flow $0 $433,000 $343,000 $27,637
Cash Flow From Continuing Investing Activities $0 $433,000 $343,000 $27,637
Net Other Investing Changes - $433,000 $343,000 -
Financing Activities
Financing Cash Flow $200,000 $0 $341,632 $525,003
Cash Flow From Continuing Financing Activities $200,000 $0 $341,632 $525,003
Issuance Of Capital Stock - - - $0
Net Common Stock Issuance - - - $0
Common Stock Issuance - - - $0
Other
Repayment Of Debt $-70,000 $0 - -
Issuance Of Debt $270,000 $0 $341,632 $525,003
Income Tax Paid Supplemental Data $2,400 $2,400 $2,400 $2,400
End Cash Position $115,019 $156,178 $220,645 $226,142
Beginning Cash Position $156,178 $220,645 $226,142 $352,738
Changes In Cash $-41,159 $-64,467 $-5,497 $-126,596
Net Issuance Payments Of Debt $200,000 $0 $341,632 $525,003
Net Short Term Debt Issuance $200,000 $0 - -
Short Term Debt Payments $-70,000 $0 - -
Short Term Debt Issuance $270,000 $0 - -
Change In Working Capital $600,978 $879,358 $1,644,637 $1,516,286
Change In Other Working Capital $582,741 $785,779 $1,007,835 $26,078
Change In Payables And Accrued Expense $604,215 $862,081 $1,641,917 $1,482,211
Change In Accrued Expense $587,828 $877,067 $1,621,966 $1,454,712
Change In Payable $16,387 $-14,986 $19,951 $27,499
Change In Account Payable $16,387 $-14,986 $19,951 $27,499
Change In Prepaid Assets $-3,237 $17,277 $2,720 $7,997
Other Non Cash Items $74,979 $89,175 $151,581 $160,148
Stock Based Compensation $4,867 $21,935 $295,123 $1,308,008
Net Income From Continuing Operations $-921,983 $-1,008,235 $-2,380,870 $-3,684,478
Interest Paid Supplemental Data - $0 $0 $0
Net Long Term Debt Issuance - $0 $341,632 $525,003
Long Term Debt Issuance - $0 $341,632 $525,003
Gain Loss On Investment Securities - $-479,700 $-400,600 $20,800
Net Business Purchase And Sale - - $0 $27,637
Sale Of Business - - $0 $27,637
Earnings Losses From Equity Investments - - - $0
Fetched: 2026-02-02